QSAR model for cytotoxicity of SiO2 nanoparticles on human lung fibroblasts

Journal of Nanoparticle Research

Volumn 16, Issue 2, 2014, Pages

  Toropova, Alla P ^a   Toropov, Andrey A ^a   Benfenati, Emilio ^a   Korenstein, Rafi ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

CORAL software; Health effects; Modeling and simulation; Optimal descriptor; QSAR; SiO2 nanoparticle

Indexed keywords

EID: 84893181595     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-014-2282-9     Document Type: Article

References (49)

1. Afantitis A, Melagraki G, Sarimveis H, Igglessi-Markopoulou O, Kollias G (2009) A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas. Eur J Med Chem 44:877-884
2. Afantitis A, Melagraki G, Koutentis PA, Sarimveis H, Kollias G (2011) Ligand-based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks. Eur J Med Chem 46:497-508
3. Cattaneo AG, Gornati R, Sabbioni E, Chiriva-Internati M, Cobos E, Jenkins MR, Bernardini G (2010) Nanotechnology and human health: risks and benefits. J Appl Toxicol 30:730-744
4. 2 shell for removal of microcystins. J Am Chem Soc 130:28-29
5. Fourches D, Pu D, Tassa C, Weissleder R, Shaw SY, Mumper RJ, Tropsha A (2010) Quantitative nanostructure-activity relationship modeling. ACS Nano 4:5703-5712
6. Furtula B, Gutman I (2011) Relation between second and third geometric-arithmetic indices of trees. J Chemometr 25:87-91
7. Gajewicz A, Rasulev B, Dinadayalane TC, Urbaszek P, Puzyn T, Leszczynska D, Leszczynski J (2012) Advancing risk assessment of engineered nanomaterials: application of computational approaches. Adv Drug Deliv Rev 64:1663-1693
8. García J, Duchowicz PR, Rozas MF, Caram JA, Mirífico MV, Fernández FM, Castro EA (2011) A comparative QSAR on 1,2,5- thiadiazolidin-3-one 1,1-dioxide compounds as selective inhibitors of human serine proteinases. J Mol Graph Model 31:10-19
9. Garro Martinez JC, Duchowicz PR, Estrada MR, Zamarbide GN, Castro EA (2011) QSAR study, molecular design of open-chain enaminones as anticonvulsant agents. Int J Mol Sci 12:9354-9368
10. González MP, Toropov AA, Duchowicz PR, Castro EA (2004) QSPR calculation of normal boiling points of organic molecules based on the use of correlation weighting of atomic orbitals with extended connectivity of zero- and first-order graphs of atomic orbitals. Molecules 9:1019-1033
11. Hollas B, Gutman I, Trinajstić N (2005) On reducing correlations between topological indices. Croat Chem Acta 78:489-492
12. Ibezim E, Duchowicz PR, Ortiz EV, Castro EA (2012) QSAR on aryl-piperazine derivatives with activity on malaria. Chemometr Intell Lab Syst 110:81-88
13. Ivanciuc T, Ivanciuc O, Klein DJ (2006) Modeling the bioconcentration factors and bioaccumulation factors of polychlorinated biphenyls with posetic quantitative super-structure/activity relationships (QSSAR). Mol Divers 10:133-145
14. Leszczynski J (2010) Bionanoscience: Nano meets bio at the interface. Nat Nanotech 5:633-634
15. Li W, Samra DA, Merzaban J, Khashab NM (2013) P-glycoprotein targeted nanoscale drug carriers. J Nanosci Nanotech 13:1399-1402
16. Marinescu G, Patron L, Culita DC, Neagoe C, Lepadatu CI, Balint I, Bessais L, Cizmas CB (2006) Synthesis of magnetite nanoparticles in the presence of aminoacids. J Nanopart Res 8:1045-1051
17. Melagraki G, Afantitis A (2011) Ligand and structure based virtual screening strategies for hit-finding and optimization of Hepatitis C virus (HCV) inhibitors. Curr Med Chem 18:2612-2619
18. Melagraki G, Afantitis A, Sarimveis H, Igglessi-Markopoulou O, Koutentis PA, Kollias G (2010) In silico exploration for identifying structure-activity relationship of MEK inhibition and oral bioavailability for isothiazole derivatives. Chem Biol Drug Des 76:397-406
19. Mullen LMA, Duchowicz PR, Castro EA (2011) QSAR treatment on a new class of triphenylmethyl-containing compounds as potent anticancer agents. Chemometr Intell Lab Syst 107:269-275
20. Nurgaliev IN, Toropov AA, Kudyshkin VO, Ruban IN, Voropaeva NL, Rashidova SSh (2006) QSPR-modeling of oligophenylene melting points. J Struct Chem 47:362-366
21. Ojha PK, Mitra I, Das RN, Roy K (2011) Further exploring rm 2 metrics for validation of QSPR models. Chemometr Intell Lab Syst 107:194-205
22. Olson MA, Braunschweig AB, Ikeda T, Fang L, Trabolsi A, Slawin AMZ, Khan SI, Stoddart JF (2009) Thermodynamic forecasting of mechanically interlocked switches. Organ Biomol Chem 7:4391-4405
23. Petrova T, Rasulev BF, Toropov AA, Leszczynska D, Leszczynski J (2011) Improved model for fullerene C 60 solubility in organic solvents based on quantum-chemical and topological descriptors. J Nanopart Res 13:3235-3247
24. Puzyn T, Leszczynska D, Leszczynski J (2009) Toward the development of "Nano-QSARs": advances and challenges. Small 5:2494-2509
25. Puzyn T, Rasulev B, Gajewicz A, Hu X, Dasari TP, Michalkova A, Hwang H-M, Toropov A, Leszczynska D, Leszczynski J (2011) Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat Nanotech 6:175-178
26. Roy K, Toropov AA (2005) QSPR modeling of the water solubility of diverse functional aliphatic compounds by optimization of correlation weights of local graph invariants. J Mol Model 11:89-96
27. Sayes C, Ivanov I (2010) Comparative study of predictive computational models for nanoparticle-induced cytotoxicity. Risk Anal 30:1723-1734
28. Thomas DG, Gaheen S, Harper SL, Fritts M, Klaessig F, Hahn-Dantona E, Paik D, Pan S, Stafford GA, Freund ET, Klemm JD, Baker NA (2013) ISA-TAB-Nano: a specification for sharing nanomaterial research data in spreadsheet-based format. BMC Biotechnol 13: art. no. 2
29. Toropov AA, Benfenati E (2007) SMILES in QSPR/QSAR modeling: results and perspectives. Curr Drug Discov Technol 4:77-116
30. Toropov AA, Leszczynski J (2006) A new approach to the characterization of nanomaterials: predicting Young's modulus by correlation weighting of nanomaterials codes. Chem Phys Lett 433:125-129
31. Toropov AA, Voropaeva NL, Ruban IN, Rashidova SSh (1999) Quantitative structure-property relationships for binary polymer-solvent systems: Correlation weighing of the local invariants of molecular graphs. Polymer Sci A 41:975-985
32. Toropov AA, Kudyshkin VO, Voropaeva NL, Ruban IN, Rashidova SSh (2001) Modeling of activity of monomers in radical copolymerization by optimization of correlation weights of local graph invariants. Polymer Sci B 43:116-119
33. Toropov AA, Kudyshkin VO, Voropaeva NL, Ruban IN, Rashidova SSh (2004) QSPR modeling of the reactivity parameters of monomers in radical copolymerizations. J Struct Chem 45:945-950
34. Toropov AA, Toropova AP, Mukhamedzhanova DV, Gutman I (2005) Simplified molecular input line entry system (SMILES) as an alternative for constructing quantitative structure-property relationships (QSPR). Indian J Chem A 44:1545-1552
35. Toropov AA, Rasulev BF, Leszczynski J (2007a) QSAR modeling of acute toxicity for nitrobenzene derivatives towards rats: comparative analysis by MLRA and optimal descriptors. QSAR Comb Sci 26:686-693
36. Toropov AA, Leszczynska D, Leszczynski J (2007b) Predicting thermal conductivity of nanomaterials by correlation weighting technological attributes codes. Mater Lett 61:4777-4780
37. Toropov AA, Toropova AP, Raska I Jr (2008a) QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES. Eur J Med Chem 43:714-740
38. Toropov AA, Toropova AP, Benfenati E (2008b) QSPR modeling for enthalpies of formation of organometallic compounds by means of SMILES-based optimal descriptors. Chem Phys Lett 461:343-347
39. Toropov AA, Rasulev BF, Leszczynski J (2008c) QSAR modeling of acute toxicity by balance of correlations. Bioorg Med Chem 16:5999-6008
40. Toropov AA, Toropova AP, Benfenati E, Manganaro A (2009a) QSAR modelling of carcinogenicity by balance of correlations. Mol Divers 13:367-373
41. Toropov AA, Toropova AP, Benfenati E, Leszczynska D, Leszczynski J (2009b) Additive InChI-based optimal descriptors: QSPR modeling of fullerene C 60 solubility in organic solvents. J Math Chem 46:1232-1251
42. Toropov AA, Toropova AP, Benfenati E (2009c) QSPR modeling of octanol water partition coefficient of platinum complexes by InChI-based optimal descriptors. J Math Chem 46:1060-1073
43. Toropov AA, Toropova AP, Benfenati E, Leszczynska D, Leszczynski J (2010a) InChI-based optimal descriptors: QSAR analysis of fullerene[C60]-based HIV-1 PR inhibitors by correlation balance. Eur J Med Chem 45:1387-1394
44. Toropov AA, Toropova AP, Benfenati E (2010b) QSAR-modeling of toxicity of organometallic compounds by means of the balance of correlations for InChI-based optimal descriptors. Mol Divers 14:183-192
45. Toropov AA, Toropova AP, Benfenati E, Leszczynska D, Leszczynski J (2010c) SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations. J Comput Chem 31:381-392
46. Toropova AP, Toropov AA, Benfenati E, Gini G (2011a) Co-evolutions of correlations for QSAR of toxicity of organometallic and inorganic substances: an unexpected good prediction based on a model that seems untrustworthy. Chemometr Intell Lab Syst 105:215-219
47. Toropova AP, Toropov AA, Benfenati E, Gini G (2011b) QSAR modelling toxicity toward rats of inorganic substances by means of CORAL Cent Eur J Chem 9:75-85
48. Toropova AP, Toropov AA, Puzyn T, Benfenati E, Leszczynska D, Leszczynski J (2013) Optimal descriptor as a translator of eclectic information into the prediction of thermal conductivity of micro-electro-mechanical systems. J Math Chem 51:2230-2237
49. 2 nanoparticles on HFL-I activating ROS-mediated apoptosis via p53 pathway. J Appl Toxicol 32:358-364